Evaluation of Safety and Efficacy of Lumason in Pediatric Echocardiography

Stopped early · Phase 3

Conditions studied: Heart Disease

In brief

Safety and Efficacy Study in pediatric subjects aged 9 to 17 years of age with suboptimal LV EBD on non-contrast 2D echocardiography. Imaging modalities that are used throughout the study in pediatric subjects represented those utilized in routine clinical practice in adults.

Key facts

Study ID
NCT02282163
Run by
Bracco Diagnostics, Inc
People needed
13
Starts
2015-10-01
Expected to finish
2018-08-01
Last updated by the study team
2020-07-13

Who can join

Age: 9 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.